Literature DB >> 22018240

VopV, an F-actin-binding type III secretion effector, is required for Vibrio parahaemolyticus-induced enterotoxicity.

Hirotaka Hiyoshi1, Toshio Kodama, Kazunobu Saito, Kazuyoshi Gotoh, Shigeaki Matsuda, Yukihiro Akeda, Takeshi Honda, Tetsuya Iida.   

Abstract

Vibrio parahaemolyticus, a Gram-negative halophilic bacterium that causes acute gastroenteritis in humans, is characterized by two type III secretion systems (T3SS), namely T3SS1 and T3SS2. T3SS2 is indispensable for enterotoxicity but the effector(s) involved are unknown. Here, we identify VopV as a critical effector that is required to mediate V. parahaemolyticus T3SS2-dependent enterotoxicity. VopV was found to possess multiple F-actin-binding domains and the enterotoxicity caused by VopV correlated with its F-actin-binding activity. Furthermore, a T3SS2-related secretion system and a vopV homologous gene were also involved in the enterotoxicity of a non-O1/non-O139 V. cholerae strain. These results indicate that the F-actin-targeting effector VopV is involved in enterotoxic activity of T3SS2-possessing bacterial pathogens.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018240     DOI: 10.1016/j.chom.2011.08.014

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  39 in total

1.  Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup Vibrio cholerae.

Authors:  Mudit Chaand; Kelly A Miller; Madeline K Sofia; Cory Schlesener; Jacob W A Weaver; Vibha Sood; Michelle Dziejman
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

Review 2.  Vibrio variations on a type three theme.

Authors:  Kelly A Miller; Katharine F Tomberlin; Michelle Dziejman
Journal:  Curr Opin Microbiol       Date:  2019-01-31       Impact factor: 7.934

3.  Characterization of V. cholerae T3SS-dependent cytotoxicity in cultured intestinal epithelial cells.

Authors:  Kelly A Miller; Mudit Chaand; Stacy Gregoire; Takeshi Yoshida; Lisa A Beck; Andrei I Ivanov; Michelle Dziejman
Journal:  Cell Microbiol       Date:  2016-07-22       Impact factor: 3.715

4.  A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation.

Authors:  Xiaohui Zhou; Benjamin E Gewurz; Jennifer M Ritchie; Kaoru Takasaki; Hannah Greenfeld; Elliott Kieff; Brigid M Davis; Matthew K Waldor
Journal:  Cell Rep       Date:  2013-04-25       Impact factor: 9.423

5.  The Transcriptional Regulator HlyU Positively Regulates Expression of exsA, Leading to Type III Secretion System 1 Activation in Vibrio parahaemolyticus.

Authors:  Landon J Getz; Nikhil A Thomas
Journal:  J Bacteriol       Date:  2018-07-10       Impact factor: 3.490

Review 6.  Subversion of the cytoskeleton by intracellular bacteria: lessons from Listeria, Salmonella and Vibrio.

Authors:  Marcela de Souza Santos; Kim Orth
Journal:  Cell Microbiol       Date:  2015-01-08       Impact factor: 3.715

7.  Genetic analysis of Vibrio parahaemolyticus intestinal colonization.

Authors:  Troy P Hubbard; Michael C Chao; Sören Abel; Carlos J Blondel; Pia Abel Zur Wiesch; Xiaohui Zhou; Brigid M Davis; Matthew K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

Review 8.  How Bacteria Subvert Animal Cell Structure and Function.

Authors:  Alyssa Jimenez; Didi Chen; Neal M Alto
Journal:  Annu Rev Cell Dev Biol       Date:  2016-05-04       Impact factor: 13.827

9.  Regulation by ToxR-Like Proteins Converges on vttRB Expression To Control Type 3 Secretion System-Dependent Caco2-BBE Cytotoxicity in Vibrio cholerae.

Authors:  Kelly A Miller; Madeline K Sofia; Jacob W A Weaver; Christopher H Seward; Michelle Dziejman
Journal:  J Bacteriol       Date:  2016-05-13       Impact factor: 3.490

Review 10.  The role of type III secretion system 2 in Vibrio parahaemolyticus pathogenicity.

Authors:  Hyeilin Ham; Kim Orth
Journal:  J Microbiol       Date:  2012-11-04       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.